Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

NCT00040027 is registered in ClinicalTrials.gov with SciClone Pharmaceuticals as lead sponsor.

NCT NCT00040027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00040027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Lead sponsor
SciClone Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2002
Completion date
Not reported
Enrollment
500
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, hepatitis c, chronic